Jian H - Search Results

1

Safety, Efficacy, and Pharmacokinetics of Almonertinib (HS-10296) in Pretreated Patients With EGFR-Mutated Advanced NSCLC: A Multicenter, Open-label, Phase 1 Trial.

Yang JC, Camidge DR, Yang CT, Zhou J, Guo R, Chiu CH, Chang GC, Shiah HS, Chen Y, Wang CC, Berz D, Su WC, Yang N, Wang Z, Fang J, Chen J, Nikolinakos P, Lu Y, Pan H, Maniam A, Bazhenova L, Shirai K, Jahanzeb M, Willis M, Masood N, Chowhan N, Hsia TC, Jian H, Lu S. Yang JC, et al. Among authors: jian h. J Thorac Oncol. 2020 Dec;15(12):1907-1918. doi: 10.1016/j.jtho.2020.09.001. Epub 2020 Sep 9. J Thorac Oncol. 2020. PMID: 32916310 Free article. Clinical Trial.

2

[Incidence, time trend, survival, and predictive factors of lung cancer in Shanghai populations].

Liao ML, Chen ZW, Zheng Y, Wu CX, Lu S, Yu YF, Jian H, Cheng BJ. Liao ML, et al. Among authors: jian h. Zhonghua Yi Xue Za Zhi. 2007 Jul 17;87(27):1876-80. Zhonghua Yi Xue Za Zhi. 2007. PMID: 17923007 Chinese.

3

Predictive significance of bone sialoprotein and osteopontin for bone metastases in resected Chinese non-small-cell lung cancer patients: a large cohort retrospective study.

Zhang L, Hou X, Lu S, Rao H, Hou J, Luo R, Huang H, Zhao H, Jian H, Chen Z, Liao M, Wang X. Zhang L, et al. Among authors: jian h. Lung Cancer. 2010 Jan;67(1):114-9. doi: 10.1016/j.lungcan.2009.03.017. Lung Cancer. 2010. PMID: 19376608

4

[The possibility to establish the scale of quality of life (QOL) fit for Chinese lung cancer patients].

Lu S, Liao M, Shen J, Shi C, Jian H. Lu S, et al. Among authors: jian h. Zhongguo Fei Ai Za Zhi. 2001 Oct 20;4(5):344-6. doi: 10.3779/j.issn.1009-3419.2001.05.08. Zhongguo Fei Ai Za Zhi. 2001. PMID: 21059313 Free article. Chinese.

5

A cost-effectiveness analysis of docetaxel versus pemetrexed in second-line chemotherapy for stage IIIb or IV non-small cell lung cancer in China.

Yu YF, Chen ZW, Zhou Z, Song ZB, Li ZM, Jian H, Zhang YF, Lu S. Yu YF, et al. Among authors: jian h. Chemotherapy. 2010;56(6):472-7. doi: 10.1159/000321016. Epub 2010 Nov 23. Chemotherapy. 2010. PMID: 21099219

6

Chinese pediatric and adolescent primary tracheobronchial tumors: a hospital-based study.

Yu Y, Song Z, Chen Z, Jian H, Lu S. Yu Y, et al. Among authors: jian h. Pediatr Surg Int. 2011 Jul;27(7):721-6. doi: 10.1007/s00383-011-2858-8. Epub 2011 Feb 3. Pediatr Surg Int. 2011. PMID: 21290133

7

[Short-term intermittent prophylactic administration of recombinant human thrombopoietin attenuates chemotherapy-induced thrombocytopenia in lung cancer patients].

Xu YH, Cheng BJ, Lu S, Jian H, Zhou Z, Chen ZW, Ye XY. Xu YH, et al. Among authors: jian h. Zhonghua Zhong Liu Za Zhi. 2011 May;33(5):395-9. Zhonghua Zhong Liu Za Zhi. 2011. PMID: 21875475 Clinical Trial. Chinese.

8

Clinical analysis of postoperative venous thromboembolism risk factors in lung cancer patients.

Yang Y, Zhou Z, Niu XM, Li ZM, Chen ZW, Jian H, Ai XH, Cheng BJ, Liao ML, Lu S. Yang Y, et al. Among authors: jian h. J Surg Oncol. 2012 Nov;106(6):736-41. doi: 10.1002/jso.23190. Epub 2012 Jun 18. J Surg Oncol. 2012. PMID: 22711667

9

Long-term results of a randomized controlled trial evaluating preoperative chemotherapy in resectable non-small cell lung cancer.

Chen Z, Luo Q, Jian H, Zhou Z, Cheng B, Lu S, Liao M. Chen Z, et al. Among authors: jian h. Onco Targets Ther. 2013 Jun 7;6:645-50. doi: 10.2147/OTT.S44503. Print 2013. Onco Targets Ther. 2013. PMID: 23776338 Free PMC article.

10

SEMA4b inhibits MMP9 to prevent metastasis of non-small cell lung cancer.

Jian H, Zhao Y, Liu B, Lu S. Jian H, et al. Tumour Biol. 2014 Nov;35(11):11051-6. doi: 10.1007/s13277-014-2409-8. Epub 2014 Aug 6. Tumour Biol. 2014. PMID: 25095981

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

525 results

Search Page

Filters